You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 12, 2024

COREG CR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Coreg Cr, and what generic alternatives are available?

Coreg Cr is a drug marketed by Waylis Therap and is included in one NDA. There is one patent protecting this drug and three Paragraph IV challenges.

This drug has twenty-four patent family members in fourteen countries.

The generic ingredient in COREG CR is carvedilol phosphate. There are thirty-seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the carvedilol phosphate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Coreg Cr

A generic version of COREG CR was approved as carvedilol phosphate by SUN PHARM INDUSTRIES on October 25th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for COREG CR?
  • What are the global sales for COREG CR?
  • What is Average Wholesale Price for COREG CR?
Drug patent expirations by year for COREG CR
Drug Prices for COREG CR

See drug prices for COREG CR

Drug Sales Revenue Trends for COREG CR

See drug sales revenues for COREG CR

Paragraph IV (Patent) Challenges for COREG CR
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
COREG CR Extended-release Capsules carvedilol phosphate 10 mg and 20 mg 022012 1 2008-03-18
COREG CR Extended-release Capsules carvedilol phosphate 40 mg 022012 1 2007-12-21
COREG CR Extended-release Capsules carvedilol phosphate 80 mg 022012 1 2007-11-19

US Patents and Regulatory Information for COREG CR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Waylis Therap COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-001 Oct 20, 2006 AB RX Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Waylis Therap COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-004 Oct 20, 2006 AB RX Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Waylis Therap COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-002 Oct 20, 2006 AB RX Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Waylis Therap COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-003 Oct 20, 2006 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for COREG CR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Waylis Therap COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-003 Oct 20, 2006 ⤷  Sign Up ⤷  Sign Up
Waylis Therap COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-004 Oct 20, 2006 ⤷  Sign Up ⤷  Sign Up
Waylis Therap COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-002 Oct 20, 2006 ⤷  Sign Up ⤷  Sign Up
Waylis Therap COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-003 Oct 20, 2006 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for COREG CR

See the table below for patents covering COREG CR around the world.

Country Patent Number Title Estimated Expiration
Finland 70406 ⤷  Sign Up
Japan 3546058 ⤷  Sign Up
Singapore 52284 ⤷  Sign Up
Mexico PA04003367 FORMULACION ORAL MICROPARTICULADA GALENICA PARA LA LIBERACION RETRASADA Y CONTROLADA DE PRINCIPIOS ACTIVOS FARMACEUTICOS. (GALENIC MICROPARTICULATE ORAL FORMULATION.) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.